Arcus Biosciences (RCUS) Cash from Investing Activities (2017 - 2026)
Arcus Biosciences' Cash from Investing Activities was $52 million in Q2 2026, down 62.0% from $137 million a year earlier and down 54.4% from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Cash from Investing Activities (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Arcus Biosciences' Cash from Investing Activities was $63 million through Jun 30, 2026, down 67.0% year-over-year; for FY2025, it came in at $66 million.
- In earlier years, Cash from Investing Activities was -$84 million in FY2024, $194 million in FY2023, -$413 million in FY2022 and -$4 million in FY2021.
- Quarterly Cash from Investing Activities has moved between -$268 million (Q1 2022) and $137 million (Q2 2025) over five years.
- Compared with a year earlier, Cash from Investing Activities was higher in three of the last four quarters, with growth averaging 98.5%.
- The best year-over-year quarter for Cash from Investing Activities over five years was Q1 2026 (growth of 256.3%); the worst was Q2 2026 (a decline of 62.0%).
- Per Business Quant data, RCUS's Cash from Investing Activities in the three quarters before Q2 2026 was $114 million (Q1 2026), -$182 million (Q4 2025) and $79 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Arcus Biosciences | 3.11 Bn | -229.58 Mn | - | 52.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 52.00 Mn |
| Mar 31, 2026 | 114.00 Mn |
| Dec 31, 2025 | -182.00 Mn |
| Sep 30, 2025 | 79.00 Mn |
| Jun 30, 2025 | 137.00 Mn |
| Mar 31, 2025 | 32.00 Mn |
| Dec 31, 2024 | 51.00 Mn |
| Sep 30, 2024 | -29.00 Mn |
| Jun 30, 2024 | 63.00 Mn |
| Mar 31, 2024 | -169.00 Mn |
| Dec 31, 2023 | 28.00 Mn |
| Sep 30, 2023 | 11.00 Mn |
| Jun 30, 2023 | 26.00 Mn |
| Mar 31, 2023 | 129.00 Mn |
| Dec 31, 2022 | 47.00 Mn |
| Sep 30, 2022 | 23.00 Mn |
| Jun 30, 2022 | -215.00 Mn |
| Mar 31, 2022 | -268.00 Mn |
| Dec 31, 2021 | 18.78 Mn |
| Sep 30, 2021 | -88.61 Mn |
API Access
Arcus Biosciences Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();